CCSD code B3015 – Breast reconstruction using fixed prosthesis

Key takeaways

CCSD code B3015 covers breast reconstruction with a fixed, non-expandable prosthesis, whether immediate or delayed.

The phrase ‘including delayed reconstruction’ in the descriptor means one code covers both timing scenarios.

Pre-authorization from Bupa, AXA Health, and Vitality is required before the procedure in almost every case.

The prosthesis device cost is not bundled into B3015 and must be agreed separately with the insurer.

Pabau supports CCSD code lookup and claim preparation before submission to Healthcode.

CCSD code B3015: Definition and descriptor

CCSD code B3015 is defined by the Clinical Coding and Schedule Development (CCSD) Group as: Reconstruction of breast using fixed prosthesis (including delayed reconstruction). It sits in Chapter 7, Breast, of the CCSD fee schedule. That schedule is the coding standard used across all major UK private medical insurance (PMI) providers, including Bupa, AXA Health, Vitality Health, WPA, and Aviva.

The key clinical qualifier in this descriptor is “fixed prosthesis.” This distinguishes B3015 from codes covering tissue expanders or multi-stage implant exchange procedures. A fixed prosthesis is a permanent, non-expandable silicone implant inserted in a single operative stage. Once placed, it is not inflated or exchanged as part of the reconstruction pathway coded here.

The parenthetical “(including delayed reconstruction)” confirms that B3015 applies in both timings. It covers the implant inserted at the time of mastectomy and the one inserted later as a staged procedure. Coders do not need a separate code for the delayed scenario. Timing changes the documentation and billing context, but the procedure code itself remains B3015.

What the procedure involves

Breast reconstruction using a fixed prosthesis creates a breast mound with a permanent silicone implant. The implant sits beneath the pectoralis major muscle or in a pre-pectoral plane. The procedure is performed by a consultant plastic or oncoplastic surgeon in a hospital setting. Billing teams reviewing these claims need to recognize the surgical scope in the operative note before they code it.

The main clinical scenarios covered by B3015 are:

• Immediate reconstruction: the implant is placed at the same operative session as the therapeutic mastectomy. The mastectomy is coded separately, typically with a breast surgery code from the same CCSD chapter. B3015 covers the reconstructive component only.
• Delayed reconstruction: the patient has previously undergone mastectomy, often via the NHS for oncological treatment. They present to a private surgeon at a later date for reconstruction, and B3015 covers that staged procedure as a standalone episode.
• Reconstruction after prophylactic mastectomy: patients at high genetic risk (BRCA1/2) who elect risk-reducing mastectomy and reconstruction with a fixed implant. Diagnosis coding differs from the oncological scenario.

The NICE guideline NG101 on breast reconstruction following breast cancer treatment is referenced by insurers when they assess medical necessity. It supports both immediate and delayed implant-based reconstruction where that is clinically appropriate.

Immediate vs delayed breast reconstruction: Billing differences

Both immediate and delayed scenarios use CCSD code B3015 for the reconstructive procedure itself. What changes between them is the billing context. That means the companion codes on the claim, the ICD-10 diagnosis codes, the authorization episode, and the documentation the insurer expects.

For delayed cases where the mastectomy was performed on the NHS, confirm the insurer’s position on NHS-to-private pathway continuity. Some PMI providers want written confirmation that the private consultant has reviewed the original diagnosis and treatment pathway before they authorize the reconstruction episode.

Codes commonly used alongside B3015

CCSD code B3015 rarely appears alone on a claim. The codes below are those most frequently billed on the same invoice or within the same authorized episode. Verify companion code rules against current insurer schedules, as bundling policies vary by PMI provider.

Anesthetic fees on a B3015 case are always submitted separately, on the anesthetist’s own invoice. Surgeons should not include them within their own B3015 claim.

Neighboring CCSD codes and how to tell them apart

Chapter 7 of the CCSD schedule contains several codes that describe different reconstruction techniques. Selecting the wrong one is the most common coding error on B3015 claims. The differentiator is always the reconstructive method used: fixed implant, tissue expander, autologous flap, or a later volume adjustment. Check the descriptor in the current CCSD code schedule before you assign a code.

The most frequent coding error is billing B3015 when the operative note describes placement of a tissue expander. B3014 is the correct code in that case. Billing a fixed prosthesis code for an expander insertion is caught on clinical review by the insurer’s medical assessors. The result is a denial, or a request for supporting documentation. Always confirm from the operative note that the device inserted is described as fixed or permanent.

Documentation requirements for B3015 claims

Incomplete documentation is the leading cause of B3015 claim denials. Insurers assess these claims against their internal medical necessity criteria and against the clinical record provided. The operative note is the foundation, and every other document supports it.

The minimum documentation set for a B3015 claim is:

• Operative note specifying that a fixed prosthesis was inserted, including implant type, manufacturer, reference number, and size. The word “fixed” or “permanent” must appear. A note that says only “implant inserted” invites a request for further information.
• Authorization reference number linked to the B3015 procedure code in the claim submission. Submitting without a valid authorization reference is an automatic denial trigger across all major PMI providers.
• Confirmed indication with supporting evidence. That means an oncology MDT outcome letter for post-cancer reconstruction, a genetic counseling report for prophylactic cases, or clinical photographs for trauma and congenital cases.
• ICD-10 diagnosis code matched to the clinical indication. Use C50.x for active malignancy, Z42.1 for aftercare following reconstruction, and Z80.3 or Z85.3 for genetic risk and personal history. Verify against the current ICD-10 edition.
• Consultant letter confirming the decision to proceed with fixed prosthesis reconstruction. This matters most for delayed cases, where significant time has elapsed since the mastectomy.

An operative note template with structured fields for implant type, plane of placement, and device identifiers removes most of the ambiguity that triggers insurer queries. Capturing those details at the point of care also cuts the administrative time spent answering requests for clarification after submission.

Pre-authorization: What UK insurers require

Authorization is required for B3015 by all major UK PMI providers. Bupa, AXA Health, and Vitality Health all classify breast reconstruction as a major elective surgical procedure. All three require authorization before the procedure takes place. Retrospective requests are rarely approved. The Bupa CCSD codes guide sets out the Bupa-specific code and authorization requirements.

The process differs slightly by insurer, but the clinical evidence set is broadly consistent:

• Bupa: Use the Bupa provider portal or call the Bupa authorization line. Submit the consultant’s clinical letter, the diagnosis code, and the proposed CCSD procedure code. For oncological cases, an MDT outcome letter is standard. Bupa’s code search tool at codes.bupa.co.uk confirms the current procedure description.
• AXA Health: Submit via the AXA Health specialist procedure portal. AXA may ask for a pathology report confirming the original diagnosis in cancer cases, plus a clinical letter from the treating consultant for delayed reconstructions.
• Vitality Health: Check the Vitality fee finder for the current CCSD fee and authorization pathway. Vitality asks for clinical evidence of medical necessity. For delayed reconstruction, that usually means a consultant letter explaining why the patient is now seeking private treatment.
• WPA, Aviva, Cigna: Each operates its own authorization portal, and all three treat B3015 as requiring authorization. Verify current requirements directly with each insurer before submission.

Authorization references have episode windows. Confirm the window length with the insurer at the point of authorization, and make sure the procedure takes place inside it. If the date moves because of patient fitness or scheduling, apply for an extension before the window expires rather than after.

Build authorization tracking into the practice management system so that no B3015 procedure is booked without a valid reference already on file. A booking made ahead of the authorization is the single easiest denial to prevent.

Common reasons B3015 claims are denied

B3015 denials follow predictable patterns, and each one bites at a specific point in the claim’s path. Addressing them in order lets a billing team fix the risk before submission rather than after rejection.

• Missing or expired authorization: The most frequent denial reason. Submit only after confirming the authorization reference is valid and the episode window has not closed.
• Wrong code: expander billed as fixed prosthesis. If the operative note describes a tissue expander, B3014 applies. Billing B3015 for an expander is a coding error the insurer’s clinical team will identify on review.
• Incomplete operative note: Missing implant manufacturer details, size, reference number, or the terms “fixed” and “permanent”. Insurers are entitled to request full operative documentation, and a sparse note delays payment.
• Mismatched diagnosis code: An active malignancy code used for a patient in remission is one version. Another is a follow-up code used for an immediate reconstruction during the mastectomy admission. The diagnosis code must reflect the patient’s status on the day.
• Billing outside the authorized episode window: The procedure date on the claim falls outside the dates the authorization reference covers. Apply for an extension before submitting if the dates have shifted.
• Implant cost included in the procedural fee without separate agreement: Recovering the prosthesis cost inside the B3015 fee when no separate implant cost agreement exists. The section below covers how that cost should be handled.

Mapped onto the claim’s path, those six reasons resolve into five checkpoints between authorization and submission:

Does B3015 include the cost of the implant?

CCSD code B3015 covers the surgical procedure fee only. The prosthesis device cost is not bundled into it and must be agreed separately with the insurer. This is the most commonly misunderstood part of fixed prosthesis billing, and recovering the implant cost the wrong way is a denial risk.

The implant cost recovery process works as follows:

• Separate insurer agreement: Most major PMI providers have their own implant cost policy. Typically the hospital or practice submits the implant invoice separately, or under a device cost line item. The mechanism varies by insurer.
• Self-pay scenarios: Where the patient funds the procedure personally, the implant cost is invoiced directly to them. It sits alongside the surgical fee as a separate line item.
• Hospital supply agreements: Where surgery takes place at a private hospital, the hospital typically bills the implant cost directly. The surgeon’s invoice then covers B3015 only.
• Do not inflate the B3015 fee to cover implant costs: Absorbing an unrecovered implant cost into the fee creates a discrepancy against the CCSD schedule. Insurers identify it during audit.

Verify the implant cost recovery pathway with each insurer before the procedure date, not after. Policies change, and what Bupa accepted in a previous episode may need renegotiating under current provider agreements.

Billing B3015 through Healthcode

Healthcode is the primary electronic invoicing platform for UK private medical billing. Most consultants and private hospitals use it to submit claims to Bupa, AXA Health, Vitality, and other PMI providers. Submitting B3015 through it follows a structured workflow that mirrors the insurer’s authorization requirements.

The standard Healthcode submission steps for B3015 are:

1. Open the invoice form in the Healthcode portal and select the relevant insurer and membership number.
2. Enter CCSD code B3015 in the procedure code field. The portal validates the code against the current CCSD schedule and confirms the descriptor.
3. Link the authorization reference number to the procedure line. Healthcode requires an authorization reference for surgical procedures of this type, and the submission will not pass validation without it.
4. Add the ICD-10 diagnosis code in the diagnosis field. Select the code that matches the clinical indication.
5. Complete the procedure date and consultant details. The procedure date must fall within the authorization window.
6. Submit and retain the Healthcode submission reference for follow-up. If the claim is queried, that reference locates the submission in the insurer’s system.

Re-keying the code, the authorization reference, and the diagnosis code by hand is where most submission errors start. Holding the clinical record and the billing workflow in one system removes that step entirely.

CQC registration and PHIN reporting

Breast reconstruction using a fixed prosthesis takes place in registered private hospital settings in England. The Care Quality Commission regulates those settings under the Health and Social Care Act 2008. Scotland, Wales, and Northern Ireland have separate oversight for private healthcare, so provider obligations differ by nation. None of this changes how B3015 is coded, but it does affect the facility details an insurer expects to see on the authorization record.

Private Healthcare Information Network (PHIN) transparency reporting applies to private hospitals in England, and procedures coded under B3015 may fall within its scope. Consultants and hospitals should confirm their reporting obligations with the hospital’s compliance team. The CCSD technical guide sets out the business rules governing code structure, unbundling, and co-billing across the schedule.

How Pabau supports CCSD claim preparation

Most UK private billing teams assemble a B3015 claim from three places. The operative note sits in the clinical system, the authorization reference in a spreadsheet, and the invoice in the Healthcode portal. Every detail that decides whether the claim clears has to be copied across by hand.

Practice management software like Pabau keeps those details on one patient record. The operative note, the implant manufacturer and reference number, the authorization reference, and the CCSD code all live together. Billing staff prepare and review the claim there, then send it to Healthcode with nothing re-typed.

That matters most on the fields B3015 claims fail on. Billing teams who want faster claims management get the authorization reference, its expiry date, and the procedure code on one screen. A window that has already closed shows up before the invoice leaves the practice, not six weeks later in a denial letter.

Manage CCSD billing workflows in one place

Pabau supports CCSD code lookup, authorization tracking, and claim preparation before submission to Healthcode. See how UK billing teams cut submission errors and speed up payment recovery.

Book a demo

Conclusion

Getting B3015 right comes down to three things. The operative note has to confirm a fixed prosthesis. The authorization reference has to be valid and in window, and the diagnosis code has to match the clinical scenario. When all three line up, the claim clears. When one is missing, the denial is close to certain and the resolution is slow.

Notice how little of that can be fixed at submission. Four of the five checkpoints are already decided by the time the invoice is written. The work that protects a B3015 claim happens in the weeks before it, not in the minutes before you press send.

Pabau gives UK private billing teams one workflow for CCSD code selection, authorization tracking, and claim preparation. Errors surface before the invoice goes out rather than weeks after a denial. Book a demo to see how that works on a breast reconstruction claim.

Continue your research

Need the full Bupa procedure code schedule? Bupa CCSD codes guide covers the code and authorization requirements Bupa applies to UK private practitioners.

Billing a mastectomy and reconstruction on one claim? CCSD code B3012 covers mastectomy with immediate expandable prosthesis reconstruction, unilateral.

Coding an autologous reconstruction instead? CCSD code B2985 covers free TRAM flap reconstruction, where no implant is used.

Working through a rejected invoice? Denial codes in medical billing explains what each rejection code means and how to respond to it.

Frequently asked questions